Opioid Withdrawal Treatment Market
Opioid Withdrawal Treatment Market - Global Industry Assessment & Forecast
Segments Covered
- By Treatment Type Medication-Assisted Treatment (MAT), Non-Medication-Based Therapy, Detoxification Treatment, Behavioral Therapy
- By Drug Type Buprenorphine, Methadone, Naltrexone, Clonidine, Lofexidine
- By End-User Hospitals & Clinics, Rehabilitation Centers, Homecare Settings, Specialty Treatment Centers
- By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Treatment Programs (Government and Private)
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2024 |
Forecast Years: | 2025 - 2034 |
Historical Years: | 2019 - 2023 |
Revenue 2024: | USD 1.24 Billion |
Revenue 2034: | USD 3.26 Billion |
Revenue CAGR (2025 - 2034): | 10. 1% |
Fastest Growing Region (2025 - 2034) | North America |
Largest Region (2024): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Opioid Withdrawal Treatment Market - Segment Analysis
- Overview
- Global Opioid Withdrawal Treatment Market, 2016 - 2028 (USD Million)
-
Global Opioid Withdrawal Treatment Market - by Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
-
Global Opioid Withdrawal Treatment Market - by Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
-
Global Opioid Withdrawal Treatment Market - by End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
-
Global Opioid Withdrawal Treatment Market - by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
-
Global Opioid Withdrawal Treatment Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Opioid Withdrawal Treatment Market - Segment Analysis
- Overview
- North America Opioid Withdrawal Treatment Market, 2016 - 2028 (USD Million)
-
North America Opioid Withdrawal Treatment Market, by Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
-
North America Opioid Withdrawal Treatment Market, by Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
-
North America Opioid Withdrawal Treatment Market, by End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
-
North America Opioid Withdrawal Treatment Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
-
North America Opioid Withdrawal Treatment Market, by Country
- U.S.
- U.S. Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- U.S. Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- U.S. Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- U.S. Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- U.S. Opioid Withdrawal Treatment Market, By Treatment Type
- Canada
- Canada Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Canada Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Canada Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Canada Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Canada Opioid Withdrawal Treatment Market, By Treatment Type
- Mexico
- Mexico Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Mexico Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Mexico Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Mexico Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Mexico Opioid Withdrawal Treatment Market, By Treatment Type
- U.S.
-
Europe Opioid Withdrawal Treatment Market - Segment Analysis
- Overview
- Europe Opioid Withdrawal Treatment Market, 2016 - 2028 (USD Million)
-
Europe Opioid Withdrawal Treatment Market, by Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
-
Europe Opioid Withdrawal Treatment Market, by Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
-
Europe Opioid Withdrawal Treatment Market, by End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
-
Europe Opioid Withdrawal Treatment Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
-
Europe Opioid Withdrawal Treatment Market, by Country
- Germany
- Germany Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Germany Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Germany Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Germany Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Germany Opioid Withdrawal Treatment Market, By Treatment Type
- UK
- UK Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- UK Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- UK Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- UK Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- UK Market, By Treatment Type
- France
- France Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- France Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- France Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- France Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- France Opioid Withdrawal Treatment Market, By Treatment Type
- Spain
- Spain Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Spain Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Spain Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Spain Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Spain Opioid Withdrawal Treatment Market, By Treatment Type
- Italy
- Italy Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Italy Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Italy Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Italy Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Italy Opioid Withdrawal Treatment Market, By Treatment Type
- BENELUX
- BENELUX Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- BENELUX Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- BENELUX Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- BENELUX Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- BENELUX Opioid Withdrawal Treatment Market, By Treatment Type
- Rest of Europe
- Rest Of Europe Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Rest Of Europe Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Rest Of Europe Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Rest Of Europe Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Rest Of Europe Opioid Withdrawal Treatment Market, By Treatment Type
- Germany
-
Asia Pacific Opioid Withdrawal Treatment Market - Segment Analysis
- Overview
- Asia Pacific Opioid Withdrawal Treatment Market, 2016 - 2028 (USD Million)
-
Asia Pacific Opioid Withdrawal Treatment Market, by Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
-
Asia Pacific Opioid Withdrawal Treatment Market, by Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
-
Asia Pacific Opioid Withdrawal Treatment Market, by End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
-
Asia Pacific Opioid Withdrawal Treatment Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
-
Asia Pacific Opioid Withdrawal Treatment Market, by Country
- China
- China Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- China Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- China Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- China Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- China Opioid Withdrawal Treatment Market, By Treatment Type
- Japan
- Japan Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Japan Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Japan Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Japan Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Japan Opioid Withdrawal Treatment Market, By Treatment Type
- India
- India Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- India Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- India Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- India Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- India Opioid Withdrawal Treatment Market, By Treatment Type
- South Korea
- South Korea Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- South Korea Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- South Korea Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- South Korea Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- South Korea Opioid Withdrawal Treatment Market, By Treatment Type
- South East Asia
- South East Asia Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- South East Asia Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- South East Asia Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- South East Asia Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- South East Asia Opioid Withdrawal Treatment Market, By Treatment Type
- Rest of Asia Pacific
- Rest of Asia Pacific Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Rest of Asia Pacific Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Rest of Asia Pacific Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Rest of Asia Pacific Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Rest of Asia Pacific Opioid Withdrawal Treatment Market, By Treatment Type
- China
-
Latin America Opioid Withdrawal Treatment Market - Segment Analysis
- Overview
- Latin America Opioid Withdrawal Treatment Market, 2016 - 2028 (USD Million)
-
Latin America Opioid Withdrawal Treatment Market, by Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
-
Latin America Opioid Withdrawal Treatment Market, by Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
-
Latin America Opioid Withdrawal Treatment Market, by End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
-
Latin America Opioid Withdrawal Treatment Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
-
Latin America Opioid Withdrawal Treatment Market, by Country
- Brazil
- Brazil Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Brazil Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Brazil Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Brazil Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Brazil Opioid Withdrawal Treatment Market, By Treatment Type
- Argentina
- Argentina Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Argentina Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Argentina Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Argentina Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Argentina Opioid Withdrawal Treatment Market, By Treatment Type
- Rest of Latin America
- Rest of Latin America Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Rest of Latin America Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Rest of Latin America Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Rest of Latin America Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Rest of Latin America Opioid Withdrawal Treatment Market, By Treatment Type
- Brazil
-
Middle East & Africa Opioid Withdrawal Treatment Market - Segment Analysis
- Overview
- Middle East & Africa Opioid Withdrawal Treatment Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Opioid Withdrawal Treatment Market, by Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
-
Middle East & Africa Opioid Withdrawal Treatment Market, by Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
-
Middle East & Africa Opioid Withdrawal Treatment Market, by End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
-
Middle East & Africa Opioid Withdrawal Treatment Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
-
Middle East & Africa Opioid Withdrawal Treatment Market, by Country
- GCC Countries
- GCC Countries Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- GCC Countries Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- GCC Countries Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- GCC Countries Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- GCC Countries Opioid Withdrawal Treatment Market, By Treatment Type
- South Africa
- South Africa Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- South Africa Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- South Africa Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- South Africa Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- South Africa Opioid Withdrawal Treatment Market, By Treatment Type
- Rest of Middle East & Africa
- Rest of Middle East & Africa Opioid Withdrawal Treatment Market, By Treatment Type
- By Medication-Assisted Treatment (MAT)
- By Non-Medication-Based Therapy
- By Detoxification Treatment
- By Behavioral Therapy
- Rest of Middle East & Africa Opioid Withdrawal Treatment Market, By Drug Type
- By Buprenorphine
- By Methadone
- By Naltrexone
- By Clonidine
- By Lofexidine
- Rest of Middle East & Africa Opioid Withdrawal Treatment Market, By End-User
- By Hospitals & Clinics
- By Rehabilitation Centers
- By Homecare Settings
- By Specialty Treatment Centers
- Rest of Middle East & Africa Opioid Withdrawal Treatment Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Drug Treatment Programs (Government and Private)
- Rest of Middle East & Africa Opioid Withdrawal Treatment Market, By Treatment Type
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Indivior PLC
- Alkermes PLC
- BioDelivery Sciences International Inc.
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Mallinckrodt Pharmaceuticals
- Orexo AB
- Hikma Pharmaceuticals
- Viatris Inc. (formerly Mylan)
- Purdue Pharma L.P.
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Opioid Withdrawal Treatment in terms of revenue?
-
The global Opioid Withdrawal Treatment valued at USD 1.24 Billion in 2024 and is expected to reach USD 3.26 Billion in 2034 growing at a CAGR of 10. 1%.
Which are the prominent players in the market?
-
The prominent players in the market are Indivior PLC, Alkermes PLC, BioDelivery Sciences International, Inc., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Mallinckrodt Pharmaceuticals, Orexo AB, Hikma Pharmaceuticals, Viatris Inc. (formerly Mylan), Purdue Pharma L.P..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 10. 1% between 2025 and 2034.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Opioid Withdrawal Treatment include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Opioid Withdrawal Treatment in 2024.